CClinicalTrials.gg
Not yet recruitingNCT06911814Updated Apr 4, 2025

The Effect of Kinesio Taping on Mobility, Pain, Balance and Daily Activities in Total Knee Replacement Patients

An interventional study of kinesio taping and THE EXERCİSE in Total Knee Anthroplasty, sponsored by Bursa City Hospital. Not yet recruiting. Open to participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-04-04.

Sponsored by Bursa City Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
50 Years to 75 Years
Sex
All
01

Study summary

Total knee arthroplasty (TKA) is a surgical procedure performed to relieve pain and functional limitations caused by advanced gonarthrosis that cannot be managed with conservative methods. It is known that the postoperative rehabilitation program plays a crucial role in functionality and mobility in the postoperative period. Pain and swelling are the most commonly reported minor complications that lead to functional limitations, often associated with decreased muscle strength. After TKA, various current methods such as compression therapy and electrotherapy are employed to treat postoperative edema. Typically, patients are discharged with a home exercise program once they are ambulatory. However, the return to daily living activities varies among patients, and some may experience prolonged recovery times. In our country and hospital, there is no standardized algorithm for postoperative care following TKA. Patients are often referred to rehabilitation clinics only when complications arise.

Due to issues with patient ambulation, there may be a need for inpatient care following TKA. While traditional rehabilitation programs are used, alternative methods to facilitate early ambulation have emerged in recent years, one of which is kinesiology taping (KT). Developed by Kenso Kase in the 1970s, KT is an elastic, wave-textured, waterproof, breathable cotton tape applied directly to the skin. When applied with various techniques, it helps alleviate pain, reduce edema, and provides mechanical support and joint protection. KT does not restrict movement; instead, its elastic structure opens the space between the dermis and fascia, aiding lymphatic and blood flow, thereby reducing swelling in the extremities. There are studies on the use of KT in postoperative patients beyond musculoskeletal pain conditions, particularly regarding its effectiveness in managing pain, swelling, and joint range of motion after shoulder and anterior cruciate ligament surgeries.

Although recent studies in the literature have explored the use of KT after TKA, there is still no consensus on its efficacy and application methods. This study aims to investigate the potential effects or complications of KT treatment on balance, pain, mobility, and quality of life in patients undergoing rehabilitation after TKA.

02

Conditions studied

  • Total Knee Anthroplasty

Keywords

  • Total knee arthroplasty
  • Kinesiotape
  • Pain
  • Edema
03

In context

Lead sponsor

Bursa City Hospital is the lead sponsor of 66 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 50-75 who have undergone total knee arthroplasty (TKA)
  • Patients able to mobilize independently
  • Patients willing to participate in the treatment program
  • Patients without any secondary conditions that could cause immobilization

Exclusion criteria

Exclusion Criteria:

  • Patients who have undergone surgery due to cancer
  • Renal insufficiency (GFR \<30)
  • Patients with local infection in the kinesiology taping application area
  • Heart failure (Stage III-IV)
  • BMI >35
  • Cognitive impairment
  • COPD (GOLD Stage III-IV)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    The exercise group

    The exercise group will receive joint range of motion exercises, strengthening exercises, and walking exercises from experienced physiotherapists while in bed.

    Other: THE EXERCİSE

  • Active comparator
    The kinesiology taping (KT) group

    On the 3rd day, the following taping will be applied to patients: a 15 cm I tape to support the medial collateral ligaments, a 20 cm Y tape for patellar tendon support, and a 25 cm Y tape to strengthen the quadriceps muscle. Additionally, KT will be applied to patients a total of three times on the 10th and 17th days.The KT group will be shown joint range of motion exercises, strengthening exercises, and walking exercises.

    Other: kinesio taping · Other: THE EXERCİSE

Interventions

  • Otherkinesio taping

    KT is an elastic, wave-textured, waterproof, breathable cotton tape applied directly to the skin.We are going to apply to patients in three times.

  • OtherTHE EXERCİSE

    KT is an elastic, wave-textured, waterproof, breathable cotton tape applied directly to the skin.We are going to apply to patients in three times.

06

What researchers measure

Primary outcomes

  1. Lysholm knee scale

    Scale is a patient-reported outcome measure used to evaluate the functional status of the knee joint (0-100 point) 95-100 points: Excellent knee function 84-94 points: Good knee function 65-83 points: Fair knee function \< 65 points: Poor knee function

    Time frame: From enrollment to the end of treatment at 3 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — opon reasonable request data observed will be provided after published

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06911814
Lead sponsor
Bursa City Hospital
Responsible party
Ömer Berkan Özcan (Physical Medicine and Rehabilitation Physician, Bursa City Hospital) — Principal investigator
First posted
Apr 4, 2025
Start date
Jun 1, 2025 (estimated)
Primary completion
Jan 1, 2026 (estimated)
Completion
Jan 1, 2026 (estimated)
Last update
Apr 4, 2025

Study contacts

Ömer Berkan ÖZCAN, License
Contact
omerberkanozcan@gmail.com
5417751963
Taner DANDİNOĞLU, MD
Contact
dandinoglu@gmail.com
5336914066

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion